X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells.

Florian M Hermann | Maya Friis Kjærgaard | Chenglei Tian | Ulf Tiemann | Abigail Jackson | Lars Rønn Olsen | Maria Kraft | Per-Ola Carlsson | Iina M Elfving | Jarno L T Kettunen | Tiinamaija Tuomi | Ivana Novak | Henrik Semb
Cell stem cell | 2023

MODY3 is a monogenic hereditary form of diabetes caused by mutations in the transcription factor HNF1A. The patients progressively develop hyperglycemia due to perturbed insulin secretion, but the pathogenesis is unknown. Using patient-specific hiPSCs, we recapitulate the insulin secretion sensitivity to the membrane depolarizing agent sulfonylurea commonly observed in MODY3 patients. Unexpectedly, MODY3 patient-specific HNF1A+/R272C β cells hypersecrete insulin both in vitro and in vivo after transplantation into mice. Consistently, we identified a trend of increased birth weight in human HNF1A mutation carriers compared with healthy siblings. Reduced expression of potassium channels, specifically the KATP channel, in MODY3 β cells, increased calcium signaling, and rescue of the insulin hypersecretion phenotype by pharmacological targeting ATP-sensitive potassium channels or low-voltage-activated calcium channels suggest that more efficient membrane depolarization underlies the hypersecretion of insulin in MODY3 β cells. Our findings identify a pathogenic mechanism leading to β cell failure in MODY3.

Pubmed ID: 36563694 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Ki67 antibody - Proliferation Marker (antibody)

RRID:AB_443209

This polyclonal targets Ki67 antibody - Proliferation Marker

View all literature mentions

HNF4A-human (antibody)

RRID:AB_2116913

This polyclonal targets HNF4A

View all literature mentions

Neuro D (A-10) (antibody)

RRID:AB_671759

This monoclonal targets Human NEUROD1

View all literature mentions

Nkx6.1 Antibody (antibody)

RRID:AB_11023606

This unknown targets Nkx6.1

View all literature mentions

Monoclonal Mouse Anti Human Smooth Muscle Actin (antibody)

RRID:AB_2223500

This monoclonal targets Smooth Muscle Actin

View all literature mentions

Alpha-1-Fetoprotein Pathology Antibody (antibody)

RRID:AB_2650473

This polyclonal targets Alpha-1-fetoprotein

View all literature mentions

Anti-βIII Tubulin mAb (antibody)

RRID:AB_430874

This monoclonal targets βIII Tubulin

View all literature mentions

Oct3/4 Antibody (C-10) (antibody)

RRID:AB_628051

This monoclonal targets Oct-3/4

View all literature mentions

Human PDX-1/IPF1 Affinity Purified Polyclonal Ab (antibody)

RRID:AB_355257

This polyclonal targets Human PDX-1/IPF1 Affinity Purified Ab

View all literature mentions

Somatostatin (D-20) (antibody)

RRID:AB_2302603

This polyclonal targets SST

View all literature mentions

Glucagon (D16G10) XP Rabbit mAb (antibody)

RRID:AB_10859908

This monoclonal targets Glucagon (D16G10) XP Rabbit mAb

View all literature mentions